ID: ALA3403522

Max Phase: Preclinical

Molecular Formula: C15H14N4O3

Molecular Weight: 298.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)Nc1ccc(C(=O)Oc2ccc(C(N)=O)cc2)cc1

Standard InChI:  InChI=1S/C15H14N4O3/c16-13(20)9-3-7-12(8-4-9)22-14(21)10-1-5-11(6-2-10)19-15(17)18/h1-8H,(H2,16,20)(H4,17,18,19)

Standard InChI Key:  QFKUAWGKUZXVPH-UHFFFAOYSA-N

Associated Targets(Human)

Hepatocyte growth factor activator 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 298.30Molecular Weight (Monoisotopic): 298.1066AlogP: 1.31#Rotatable Bonds: 4
Polar Surface Area: 131.29Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.11CX LogP: 1.46CX LogD: 0.68
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.29Np Likeness Score: -0.65

References

1. Franco FM, Jones DE, Harris PK, Han Z, Wildman SA, Jarvis CM, Janetka JW..  (2015)  Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.,  23  (10): [PMID:25882520] [10.1016/j.bmc.2015.03.072]

Source